Adam Taleb - Interventional Cardiologist
Director of the Department of Coronary Heart Disease - Chronic Total Occlusion (CTO), Structural Heart Diseases and Pulmonary Angioplasty Athens Medical Center
Adam Taleb grew up in Corfu and was admitted to the Medical School of the Aristotle University of Thessaloniki. After graduation, he completed his military service as a doctor in the outposts and minefields of the Greek border in Evros, from where he received the Distinguished Service Award, upon completion of his service. He then served in a barren rural clinic in the prefecture of Grevena and, after successfully passing the United States Medical Licensing Examinations, began his specialization in the United States of America.
Initially, he worked at the University of California, San Diego Research Center, where he studied the mechanisms of atherosclerosis and the association of the disease with lipoprotein (a) Lp (a), which is currently considered one of the risk factors for coronary artery disease. He has participated in the first experimental trials of lipoprotein (a) drugs, which are now approved by the US Pharmacological Administration (FDA) for use in patients.
He continued his specialization in Internal Medicine for 3 years at St Elizabeth TUFTS Medical Center in Boston, where he was awarded as the best trainee. He then trained in Cardiology at the University of Massachusetts, where he spent the last year serving as the Chief Cardiology Fellow, in recognition of his academic orientation. At the same time, he was certified by the American Board of Cardiac Ultrasound (NBME), after performing and reporting more than 1000 triplex, transesophageal echocardiograms and stress tests.
He completed his training in the USA in the most modern techniques of Interventional Cardiology at the University of California, performing more than 3000 surgeries. More specifically, he specialized in:
- Treatment of coronary artery disease with angioplasty, with further specialization in complex disease and chronic total occlusion (CTO)
- Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging
- Athyrectomy (Rotablation, Orbital atherectomy CSI, Laser atherectomy)
- Hemodynamic support with intraortic pump (IABP) and with the most modern Impella pump
- Structural heart disease: percutaneous valve placement in the aortic position (TAVI), mitral valve (TMVR) and pulmonary valve (Melody valve)
- Percutaneous Correction of mitral valve insufficiency with Mitraclip
- Percutaneous Closure of paravalvular regurgitation
- Treatment of congenital heart diseases (interatrial / interventricular communication, patent foramen oval, pulmonary valve insufficiency, aortic coarctation, hypertrophic obstructive cardiomyopathy)
- Left atrial appendage occlusion in patients with chronic atrial fibrillation and inability to receive anticoagulant therapy due to increased bleeding risk or history of bleeding.
- Treatment of patients with pulmonary hypertension due to chronic thromboembolic disease (CTEPH) with the method of Balloon Pulmonary Angioplasty (BPA), a technique used in a limited number of referral centers worldwide.
- Peripheral Arterial Disease: treatment of ischemia (intermittent claudication, chronic lower limb ischemia) with angioplasty, atherectomy and stent placement.
Throughout his specialization in the United States, he attended numerous international conferences, where he presented the results of his research into the mechanisms of atherosclerosis, as well as presented rare interventional cases, with pioneering techniques for treating congenital and structural disorders.
Upon his return to Greece, he started working as an Interventional Cardiologist in Advanced Coronary and Structural Cardiology at the Athens Medical Center.Download CV
Photographic material from the personal archive, during working hours and from conferences.